期刊文献+

益肾通络方对早中期慢性肾功能衰竭的疗效

Therapeutic Effect of Tonifying Kidney and Dredging Collaterals Prescription on Early and Middle Stage of Chronic Renal Failure
在线阅读 下载PDF
导出
摘要 目的:采用益肾通络方治疗早中期慢性肾功能衰竭患者,验证其有改善肾功能、延缓疾病进展方面的疗效。方法:本研究共纳入120例早中期慢性肾功能衰竭患者,随机分为治疗组和对照组,每组各60例。对照组采用纯西医药物治疗,治疗组在对照组治疗的基础上,加用益肾通络方。所有患者规律治疗1个月。治疗前后监测尿素氮(BUN)、血肌酐(Scr)及肾小球滤过率(GFR)变化。结果:经治疗后,治疗组的BUN、Scr、GFR均明显优于对照组(均P<0.05)。治疗组治疗总有效率为50.00%,明显高于对照组26.67%(P<0.05)。结论:益肾通络方联合西医基础治疗能显著降低早中期慢性肾功能衰竭患者的BUN和Scr,提高GFR,延缓肾功能恶化。 Objective:Tonifying kidney and dredging collaterals prescription is used in the treatment of patients with early and middle stage chronic renal failure.This article aims to verify the efficacy of tonifying kidney and dredging collaterals in improving renal function and delaying disease progression.Methods:A total of 120 patients with early and middle stage of chronic renal failure were enrolled and randomly divided into the treatment group and the control group,with 60 cases in each group.The control group were treated with pure Western medicine,while the treatment group were treated with tonifying kidney and dredging collaterals prescription in addition to the Western medicine.All patients were regularly treated for one month.Blood urea nitrogen(BUN),serum creatinine(Scr)and glomerular filtration rate(GFR)were monitored before and after treatment.Results:Compared to the control group,BUN,Scr and GFR in the treatment group were significantly better(all P<0.05).The effective rate was 50.00%in the treatment group,which was significantly higher than 26.67%in the control group(P<0.05).Conclusion:Tonifying kidney and dredging collaterals prescription combined with Western medicine can significantly reduce Scr and BUN,increase GFR and delay the deterioration of renal function on early and middle stage of chronic renal failure.
作者 陈杏浩 骆敏芳 Chen Xinghao;Luo Minfang(Department of Nephropathy,Meizhou Hospital of Traditional Chinese Medicine,Meizhou 514000,China;Department of Neurology,Meizhou Hospital of Traditional Chinese Medicine,Meizhou 514000,China)
出处 《巴楚医学》 2023年第1期71-74,共4页 Bachu Medical Journal
基金 梅州市中医药科研项目(No:2020-B-68)。
关键词 益肾通络方 早中期慢性肾功能衰竭 肾小球滤过率 tonifying kidney and dredging collaterals prescription early and middle stage of chronic renal failure glomerular filtration rate
作者简介 陈杏浩,男,硕士,主治医师,研究方向为中医药系统诊治肾脏疾病。E-mail:506385265@qq.com。
  • 相关文献

参考文献16

二级参考文献154

  • 1左川,谢席胜,邓尧,樊均明.黄芪对单侧输尿管梗阻大鼠肾组织转化生长因子β1表达的影响[J].中国中药杂志,2009,34(2):193-198. 被引量:15
  • 2陆晨,赵红娟,徐钢,岳华,刘伟莉,朱开春,刘晓城.Prevalence and Risk Factors Associated with Chronic Kidney Disease in a Uygur Adult Population from Urumqi[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2010,30(5):604-610. 被引量:2
  • 3陈崴,王辉,董秀清,何惠娟,刘庆华,骆宁,谭嘉庆,林建雄,聂静,毛海萍,陈维清,余学清.广州市城区普通人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2007,23(3):147-151. 被引量:172
  • 4贺玉琢.泽泻的研究——泽泻的抗肾炎活性[日]/友广教道[J].国外医学:中医中药分册,1997,19(5):58-59.
  • 5Copeland JW, Beaumont BW, Merrilees MJ, et al. Epithelial to mesenchymal transition of human proximal tubular epithelial cells: Effects of rapamycin, mycophenolate, cyclosporin, aza- thioprine, and methylprednisolone. Transplantation, 2007, 83 (6) :809 -814.
  • 6Tang Z, Lu B, Hatch E, et al. C3a mediates epithelial -to -mes- enchymal transition in proteinuric nephropathy. J Am Soc Neph- ro1,2009,20( 3 ) :593 - 603.
  • 7Matsuda H, Tomohiro N, Yoshikawa M, et al. Studies on Alismatis Rhizoma? Anti - complementary activities of methanol extract and terpene components from Alismatis Rhizoma ( dried rhizome of Alisma orientale). Biol Pharm Bull,1998,21 (12) :1317 -1321.
  • 8Lee SM, Kim JH, Zhang Y, et al. Anti - complementary activity of protostane type triterpenes from Alismatis rhizoma. Arch Pharm Res ,2003 ,26 (6) :463 - 465.
  • 9Iwano M, Plieth D, Danoff TM, et al. Evidence that fibroblasts derive from epithelium during tissure fibrosis. J Clin Invest, 2002,110(3) :341 - 350.
  • 10Lin ZH, Fukuda N, Jin XQ, et al. Complement 3 is involved in the synthetic phenotype and exaggerated growth of vascular smooth muscle ceils from spontaneously hypertensive rats. Hypertension,2004,44 ( 1 ) :42 - 47.

共引文献186

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部